Surrey Technology Centre
40 Occam Road
Guildford GU2 7YG
United Kingdom
44 14 8368 5670
https://www.futuramedical.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 12
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. James Henry Barder | CEO & Executive Director | 397,08k | N/A | 1959 |
Ms. Angela Hildreth | COO, Finance Director, Company Secretary & Executive Director | 310,8k | N/A | 1980 |
Mr. Kenneth William James | Head of R&D & Executive Director | 284,59k | N/A | 1952 |
Dr. William Duncan Potter | Chief Scientific Officer & Adviser to the Board | N/A | 143,75k | 1948 |
Graham Smith | Head of Alliance Partnerships & Supply | N/A | N/A | N/A |
Kevin Langridge | Head of Quality | N/A | N/A | N/A |
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Futura Medical plcs ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.